# Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

> **NCT00426140** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 5 (actual)

## Conditions studied

- Advanced Malignancies
- Solid Tumors

## Interventions

- **DRUG:** Patupilone

## Key facts

- **NCT ID:** NCT00426140
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2006-11
- **Final completion:** —
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426140, "Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00426140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*